• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化修饰及其对帕金森病神经退行性变的影响

Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.

作者信息

Zhao Junjun, Yu Shuqing, Zheng Yan, Yang Hui, Zhang Jianliang

机构信息

Department of Neurobiology, Beijing Institute of Brain Disorders, Capital Medical University, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Center of Neural Regeneration and Repair, Beijing Key Laboratory of Brain Major Disorders-State Key Lab Incubation Base, Beijing Neuroscience Disciplines, Beijing, 100069, China.

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, State Key Disciplinary of Neurosurgery Department, Beijing, 100050, China.

出版信息

Mol Neurobiol. 2017 Mar;54(2):1404-1418. doi: 10.1007/s12035-016-9743-3. Epub 2016 Feb 3.

DOI:10.1007/s12035-016-9743-3
PMID:26843115
Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease. The major characteristics of PD include the loss of dopaminergic neurons in the substantia nigra and Lewy body depositions. Genetic defects, environment toxicants, and aging have been recognized as risk factors for the development of PD. Currently, although the pathogenesis of PD is still obscure, overwhelming evidence demonstrates that oxidative stress plays a central role in the progress of PD. Reactive oxygen species (ROS) function mainly through chemical reactions with atomic targets that lead to covalent oxidative modifications. Through the oxidative modification of ions, amino acids, amines, and nucleic acids, ROS exert augmented effects on the structures and functions of multiple macromolecules. These oxidative modifications can affect nucleic acid stability by oxidizing RNA, increasing mitochondrial DNA (mtDNA) mutation, and launching translesion synthesis (TLS); disturb protein homeostasis by accelerating α-synuclein aggregation, parkin aggregation, and proteasome dissociation; modulate dopamine release by activating ATP-sensitive potassium channels (K) and inactivating neuronal nicotinic acetylcholine receptors (nAChRs); and influence cellular self-defenses by promoting the cytoprotective effects of DJ-1 and PTEN-induced putative kinase 1 (PINK1) while inducing Akt dysregulation. Based on the above facts, we propose that various oxidative modifications may affect nucleic acid stability, protein homeostasis, the functionality of ion channels, and cellular self-defenses and that these processes lead to protein misfolding, dopamine depletion, and further neuronal death in PD.

摘要

帕金森病(PD)是第二常见的神经退行性疾病。PD的主要特征包括黑质中多巴胺能神经元的丧失和路易小体沉积。基因缺陷、环境毒物和衰老已被认为是PD发生发展的危险因素。目前,尽管PD的发病机制仍不清楚,但大量证据表明氧化应激在PD进展中起核心作用。活性氧(ROS)主要通过与原子靶点发生化学反应发挥作用,这些反应会导致共价氧化修饰。通过对离子、氨基酸、胺和核酸的氧化修饰,ROS对多种大分子的结构和功能产生增强作用。这些氧化修饰可通过氧化RNA、增加线粒体DNA(mtDNA)突变以及启动跨损伤合成(TLS)来影响核酸稳定性;通过加速α-突触核蛋白聚集、帕金蛋白聚集和蛋白酶体解离来扰乱蛋白质稳态;通过激活ATP敏感性钾通道(K)和使神经元烟碱型乙酰胆碱受体(nAChRs)失活来调节多巴胺释放;通过促进DJ-1和PTEN诱导的假定激酶1(PINK1)的细胞保护作用同时诱导Akt失调来影响细胞自我防御。基于上述事实,我们提出各种氧化修饰可能影响核酸稳定性、蛋白质稳态、离子通道功能和细胞自我防御,并且这些过程导致PD中的蛋白质错误折叠、多巴胺耗竭和进一步的神经元死亡。

相似文献

1
Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.氧化修饰及其对帕金森病神经退行性变的影响
Mol Neurobiol. 2017 Mar;54(2):1404-1418. doi: 10.1007/s12035-016-9743-3. Epub 2016 Feb 3.
2
Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).氧化应激导致帕金森病多巴胺能神经元损伤(综述)。
Int J Mol Med. 2018 Apr;41(4):1817-1825. doi: 10.3892/ijmm.2018.3406. Epub 2018 Jan 19.
3
The role of oxidative stress in Parkinson's disease.氧化应激在帕金森病中的作用。
J Parkinsons Dis. 2013;3(4):461-91. doi: 10.3233/JPD-130230.
4
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
5
Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration.多巴胺氧化对多巴胺能神经元变性的影响。
ACS Chem Neurosci. 2019 Feb 20;10(2):945-953. doi: 10.1021/acschemneuro.8b00454. Epub 2019 Jan 17.
6
Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?帕金蛋白功能丧失病理学:高水平活性氧诱导的神经元过早衰老?
Mech Ageing Dev. 2017 Jan;161(Pt A):112-120. doi: 10.1016/j.mad.2016.06.008. Epub 2016 Jun 29.
7
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.离子通道、钙、代谢应激以及黑质多巴胺能神经元的活动模式在健康和帕金森病中的汇聚作用
J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):156-178. doi: 10.1111/jnc.13572. Epub 2016 Mar 23.
8
SUMO-regulated mitochondrial function in Parkinson's disease.小泛素样修饰物调节帕金森病中的线粒体功能。
J Neurochem. 2016 Jun;137(5):673-86. doi: 10.1111/jnc.13599. Epub 2016 Apr 5.
9
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.果蝇DJ-1的失活会导致氧化应激反应和磷脂酰肌醇3激酶/蛋白激酶B信号传导受损。
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13670-5. doi: 10.1073/pnas.0504610102. Epub 2005 Sep 9.
10
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.活性氧物种和遗传线粒体突变在帕金森病中的作用。
Gene. 2013 Dec 10;532(1):18-23. doi: 10.1016/j.gene.2013.07.085. Epub 2013 Aug 15.

引用本文的文献

1
Advances in the study of mechanisms underlying olfactory dysfunction in obstructive sleep apnea:a narrative review.阻塞性睡眠呼吸暂停嗅觉功能障碍潜在机制的研究进展:一项叙述性综述
Sleep Biol Rhythms. 2025 Apr 3;23(3):263-274. doi: 10.1007/s41105-025-00582-z. eCollection 2025 Jul.
2
Oxidative Stress: A New Pathophysiological Pathway in Parkinson's Disease and a Potential Target of the Brain-Sport Crosstalk.氧化应激:帕金森病新的病理生理途径及脑-运动交互作用的潜在靶点
Parkinsons Dis. 2025 Mar 21;2025:6691390. doi: 10.1155/padi/6691390. eCollection 2025.
3
Chinese medicine PaBing-II protects human iPSC-derived dopaminergic neurons from oxidative stress.

本文引用的文献

1
Microglial cell dysregulation in brain aging and neurodegeneration.脑衰老和神经退行性变中的小胶质细胞失调。
Front Aging Neurosci. 2015 Jul 20;7:124. doi: 10.3389/fnagi.2015.00124. eCollection 2015.
2
Role of Oxidative RNA Damage in Chronic-Degenerative Diseases.氧化RNA损伤在慢性退行性疾病中的作用。
Oxid Med Cell Longev. 2015;2015:358713. doi: 10.1155/2015/358713. Epub 2015 May 20.
3
Oxidative and other posttranslational modifications in extracellular vesicle biology.细胞外囊泡生物学中的氧化和其他翻译后修饰。
中药帕金森病Ⅱ号保护人诱导多能干细胞衍生的多巴胺能神经元免受氧化应激。
Front Immunol. 2024 Aug 2;15:1410784. doi: 10.3389/fimmu.2024.1410784. eCollection 2024.
4
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.帕金森病中调节性非编码RNA与氧化应激之间的相互作用
Front Aging Neurosci. 2022 Aug 9;14:975248. doi: 10.3389/fnagi.2022.975248. eCollection 2022.
5
Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's disease.Mortalin/Hspa9在帕金森病中的作用及治疗前景
Neural Regen Res. 2023 Feb;18(2):293-298. doi: 10.4103/1673-5374.346487.
6
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome.迷迭香二萜类化合物鼠尾草酸通过激活NRF2对抗NLRP3炎性小体在阿尔茨海默病、帕金森病和长期新冠中的潜在治疗用途
Antioxidants (Basel). 2022 Jan 6;11(1):124. doi: 10.3390/antiox11010124.
7
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson's Disease.胆碱能受体调节作为预防帕金森病痴呆的靶点
Front Neurosci. 2021 Sep 20;15:665820. doi: 10.3389/fnins.2021.665820. eCollection 2021.
8
Astroglial Hemichannels and Pannexons: The Hidden Link between Maternal Inflammation and Neurological Disorders.星形胶质细胞缝隙连接和连接蛋白通道:母体炎症与神经紊乱之间的潜在联系。
Int J Mol Sci. 2021 Sep 1;22(17):9503. doi: 10.3390/ijms22179503.
9
HSPA9/Mortalin mediates axo-protection and modulates mitochondrial dynamics in neurons.热休克蛋白 9/Mortalin 介导神经元的轴突保护和调节线粒体动力学。
Sci Rep. 2021 Sep 6;11(1):17705. doi: 10.1038/s41598-021-97162-1.
10
Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.MicroRNAs、适体在神经炎症和神经退行性疾病中的作用。
Cell Mol Neurobiol. 2022 Oct;42(7):2075-2095. doi: 10.1007/s10571-021-01093-4. Epub 2021 May 1.
Semin Cell Dev Biol. 2015 Apr;40:8-16. doi: 10.1016/j.semcdb.2015.02.012. Epub 2015 Feb 24.
4
Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels.健康与帕金森病中的多巴胺中脑神经元:电压门控钙通道和ATP敏感性钾通道的新作用
Neuroscience. 2015 Jan 22;284:798-814. doi: 10.1016/j.neuroscience.2014.10.037. Epub 2014 Oct 30.
5
The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution.神经退行性疾病中的泛素-蛋白酶体系统:促发因素,但也是解决方案的一部分。
Front Mol Neurosci. 2014 Jul 31;7:70. doi: 10.3389/fnmol.2014.00070. eCollection 2014.
6
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.全基因组关联数据的大规模荟萃分析确定了帕金森病的六个新风险位点。
Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.
7
Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.神经退行性疾病中的线粒体功能障碍:与阿尔茨海默病的相关性。
Biomed Res Int. 2014;2014:175062. doi: 10.1155/2014/175062. Epub 2014 May 12.
8
Reversible 26S proteasome disassembly upon mitochondrial stress.线粒体应激时26S蛋白酶体的可逆性解体
Cell Rep. 2014 Jun 12;7(5):1371-1380. doi: 10.1016/j.celrep.2014.04.030. Epub 2014 May 22.
9
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.一项辅酶 Q10 高剂量治疗早期帕金森病的随机临床试验:没有获益证据。
JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.
10
Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease.烟碱型乙酰胆碱受体的药理学伴侣作用:帕金森病的一个治疗靶点。
Pharmacol Res. 2014 May;83:20-9. doi: 10.1016/j.phrs.2014.02.005. Epub 2014 Mar 1.